

Health Library
October 10, 2025
Question on this topic? Get an instant answer from August.
Netupitant na palonosetron ni umuti uvura isesemi no kuruka biterwa na chimiothérapie. Uyu muti ukora mu buryo bubiri ukora ubuvuzi buhagarika inzira ebyiri zitandukanye mu bwonko bwawe zitera ibi bimenyetso bitari byiza, bikaguha uburinzi bukomeye kurusha uko umuti umwe wenyine wabikora.
Niba uri kwitegura kuvurwa na chimiothérapie, itsinda ry'abaganga bakuvura barashaka kugufasha kumva umeze neza uko bishoboka kose mu gihe cyose cyo kuvurwa. Uyu muti uvura mu buryo buhuriweho ni bumwe mu buryo bwiza dufite bwo gukumira isesemi no kuruka biterwa na chimiothérapie, bikagufasha kugumana imbaraga zawe n'ubuzima bwiza mu gihe cyo kuvurwa.
Netupitant na palonosetron bihuzwa n'imiti ibiri ikomeye ivura isesemi mu gapusule kamwe koroshye. Netupitant ni umwe mu miti yitwa NK1 receptor antagonists, mu gihe palonosetron ari 5-HT3 receptor antagonist.
Tekereza iyi miti ibiri ikora nk'ikipe y'abashinzwe umutekano ku marembo atandukanye mu bwonko bwawe. Buri umwe ahagarika inzira yihariye ubwonko bwawe bukoresha kugira ngo butere isesemi no kuruka igihe bumenye imiti ya chimiothérapie mu mubiri wawe. Uko ari babiri, batanga uburinzi bwuzuye ku ngaruka ziteye ubwoba.
Ubu buryo buhuriweho bwateguriwe abantu bakira ubuvuzi bwa chimiothérapie bumenyereweho gutera isesemi yo hagati kugeza ku ikomeye no kuruka. Muganga wawe azagusaba uyu muti nk'igice cy'uburyo bwagutse bwo gufasha mu gihe cyo kuvurwa kanseri yawe.
Uyu muti uvura mu buryo buhuriweho ukoreshwa cyane cyane mu gukumira isesemi no kuruka bifitanye isano n'ubuvuzi bwa kanseri ya chimiothérapie. Bifasha cyane cyane ku miti ya chimiothérapie yashyizwe mu cyiciro cy'imiti itera isesemi yo hagati kugeza ku ikomeye, bisobanura ko ifite imbaraga zo gutera ibi bimenyetso.
Umuvuzi wawe w’indwara z’umubiri (oncologist) ashobora kukwandikira uyu muti niba uri guhabwa imiti ya chemotherapy nka cisplatin, carboplatin, doxorubicin, cyangwa indi miti izwiho gutera isesemi n'umuriro mwinshi. Intego ni ukubuza ibi bimenyetso kubaho mbere na mbere, aho kubavura nyuma yuko byatangiye.
Uyu muti rimwe na rimwe ukoreshwa no gukumira isesemi n'umuriro bitinda, bishobora kubaho amasaha 24 kugeza kuri 120 nyuma yo gutanga imiti ya chemotherapy. Iki gihe cyatinze gishobora kuba kigoye cyane gucunga, kandi iyi mvange itanga uburinzi bwagutse muri iki gihe cy'uburwayi.
Uyu muti uvangitse ukora ubugenzuzi bwo guhagarika inzira ebyiri z'ingenzi zo mu bwonko bwawe zitera isesemi n'umuriro. Bifatwa nk'umuti wo kurwanya isesemi ukomeye cyane utanga uburinzi bwuzuye ku bimenyetso biterwa na chemotherapy.
Netupitant ikora ihagarika abakira ba NK1 mu gace k'ubwonko bwawe kitwa chemoreceptor trigger zone. Iyo imiti ya chemotherapy yinjiye mu maraso yawe, ishobora gukora aba bakira, itanga ibimenyetso bituma wumva uruka. Netupitant ikora nk'ingabo, ikabuza ibi bimenyetso guca.
Palonosetron igamije abakira ba 5-HT3, baboneka mu bwonko bwawe no mu gihe cyo mu rwungano rwawe rw'igogora. Aba bakira basubiza kuri serotonin, imiti ikora iyo umubiri wawe ubonye imiti ya chemotherapy. Mu guhagarika aba bakira, palonosetron ihagarika ibimenyetso bya isesemi mbere yuko bishobora gutuma urwara.
Ubu buryo bukorera cyane kuko buvura ibisubizo bya isesemi byihuse n'igihe cyatinze gishobora kubaho nyuma y'iminsi yo kuvurwa. Ubu burinzi bubiri bugufasha kugumana imirire myiza n'amazi menshi mugihe cyo gukoresha chemotherapy.
Fata uyu muti uko muganga wawe abigutegeka, akenshi ikinini kimwe unywa mu kanwa hafi isaha imwe mbere yuko urugero rwawe rwa kanseri rutangira. Urashobora kuwufata urya cyangwa utarya, nubwo kuwufata ufite ifunguro rito rishobora kugufasha niba wumva umubiri utameze neza.
Mimina ikinini cyose hamwe n'ikirahure cyuzuye cy'amazi. Ntugasenye, ntukore, cyangwa ufungure ikinini, kuko ibi bishobora kugira ingaruka ku buryo umuti winjizwa kandi ukarekurwa mu mubiri wawe. Niba ugira ikibazo cyo kumira ibinini, ganira n'ikipe yawe y'ubuvuzi kubyerekeye ubundi buryo.
Igihe cy'uyu muti ni ingenzi kugirango ugere ku musaruro mwinshi. Ikipe yawe y'ubuvuzi izahuza gahunda yo gutanga imiti hamwe n'igihe cyo guhura na kanseri yawe kugirango yemeze ko umuti ukora ku rwego rwo hejuru igihe ukeneye cyane.
Niba urimo guhabwa imiti ya kanseri iminsi myinshi, muganga wawe azatanga amabwiriza yihariye yerekeye igihe cyo gufata doze zinyongera. Ntukafate doze zinyongera cyangwa uhindure igihe utabanje kugisha inama umuganga wawe.
Igihe cyo kuvurwa n'uyu muti giterwa n'uburyo bwawe bwihariye bwo kuvura kanseri n'uburyo umubiri wawe witwara ku buvuzi. Abantu benshi bawufata gusa ku minsi bahabwa imiti ya kanseri, aho kuba umuti wa buri munsi.
Kubarwayi benshi, ibi bisobanura gufata doze imwe mbere ya buri cyiciro cya kanseri, gishobora kubaho buri byumweru bike bitewe na gahunda yawe yo kuvurwa. Umuganga wawe w'inzobere mu by'indwara ya kanseri azagena gahunda nyayo ishingiye ku bwoko bwa kanseri yawe, uburyo bwo kuvura, n'uburyo umuntu ku giti cye yitwara ku buvuzi.
Abantu bamwe bashobora gukenera imiti yongera kurwanya isesemi ku minsi ikurikira imiti ya kanseri, ariko iyi mvange itanga uburinzi bwagutse bushobora kumara iminsi myinshi nyuma ya doze imwe. Ikipe yawe y'ubuvuzi izagenzura uburyo umuti ukora neza kuri wewe kandi ihindure gahunda uko bikwiye.
Ntugahagarike gufata uyu muti utabanje kubaza umuganga wawe, kabone n'iyo wumva umeze neza. Intego ni ukurinda, kandi kureka imiti ishobora gutuma wibasirwa n'isuka ikabije n'umuriro bishobora kubangamira imiti ya kanseri yawe.
Kimwe n'imiti yose, netupitant na palonosetron bishobora gutera ibikorwa bigaragara, nubwo abantu benshi babihanganira neza. Ibikorwa bigaragara cyane ni ibyoroshye kandi bishobora gucungwa neza hakoreshejwe uburyo bwiza bwo kwita ku buzima no gukurikirana.
Dore ibikorwa bigaragara cyane ushobora guhura nabyo, wibuke ko abantu benshi batagira ibi byose:
Ibyinshi muri ibi bikorwa bigaragara ni ibyoroshye kandi bikunda gukira uko umubiri wawe wimenyereza umuti. Itsinda ryawe ry'ubuzima rishobora gutanga ingamba zo gucunga ibimenyetso byose bikomeza cyangwa bitera kutumva neza.
Hariho ibikorwa bigaragara bitari bike ariko bikomeye bisaba ubufasha bw'ubuvuzi bwihutirwa. Nubwo bidasanzwe, ni ngombwa kubimenya kugirango ushobore gushaka ubufasha niba bibaye ngombwa:
Niba wumva ibimenyetso bikomeye nk'ibi, vugana n'umuganga wawe ako kanya cyangwa ushake ubufasha bwihutirwa. Umutekano wawe ni wo uza imbere, kandi ibi bimenyetso bisaba isuzuma ryihuse.
Uyu muti ntukwiriye buri wese, kandi hari ibintu byihariye n'ibihe bigomba kwirindwa cyangwa gukoreshwa witonze cyane. Umuganga wawe azasuzuma neza amateka yawe y'ubuzima mbere yo kugutera uyu muti.
Ntabwo ugomba gufata uyu muti niba ufite allergie izwi kuri netupitant, palonosetron, cyangwa ibindi bice bitagira akamaro biri muri capsule. Ibimenyetso byo kwibasirwa n'umubiri birimo uruhu rurya, kubyimba, kuribwa cyane, cyangwa guhumeka nabi.
Abantu bafite indwara z'umutima zihariye bashobora gukenera gukurikiranwa by'umwihariko cyangwa imiti itandukanye. Ibi birimo abafite indwara ya congenital long QT syndrome, indwara igira ingaruka ku mutima, cyangwa abafata indi miti ishobora kugira ingaruka ku mutima.
Dore ibihe bidasanzwe aho kwitonda bikenerwa, nubwo umuti ushobora gutangwa hamwe no gukurikiranwa neza:
Itsinda ryawe ry'ubuzima rizagereranya inyungu zo gukumira isesemi n'umururumba bikomeye n'ibyago byose bishingiye ku miterere yawe bwite. Imikoranire ifunguye ku mateka yawe y'ubuzima yose ifasha kumenya gahunda y'imiti ifite umutekano ushoboka.
Umuti wa netupitant na palonosetron uboneka ku izina rya Akynzeo. Uyu ni wo muti ukoreshwa cyane w'iyi miti yombi.
Akynzeo iboneka mu buryo bw'ibinini bifite 300 mg ya netupitant na 0.5 mg ya palonosetron. Ibi binini byateguwe kugira ngo bitange urugero rwiza rw'iyi miti yombi kugira ngo bigabanye isesemi ku buryo bwiza.
Umuti wandikirwa ushobora kuba izina rya Akynzeo cyangwa uruvange rusanzwe. Byombi birimo ibintu bikora kimwe kandi bikora neza. Umufarmasi wanyu ashobora gusobanura itandukaniro iryo ariryo ryose riri hagati y'isura cyangwa ikiguzi hagati y'ubwoko bw'umuti uzwi n'usanzwe.
Nubwo uru ruvange rukora neza cyane, hariho indi miti igabanya isesemi iboneka niba udashobora gufata netupitant na palonosetron cyangwa niba bitagukundiye. Umuganga wawe ashobora kuganira kuri izi nzira zindi zishingiye ku byo ukeneye.
Izindi nkungwa za NK1 receptor zirimo aprepitant (Emend) na fosaprepitant, bikora kimwe na netupitant ariko bishobora kugira gahunda zitandukanye zo gufata imiti. Izi zishobora guhuzwa n'indi miti igabanya isesemi kugira ngo hakorwe gahunda yihariye yo kuyirinda.
Izindi nkungwa za 5-HT3 receptor zirimo ondansetron (Zofran), granisetron, na dolasetron. Iyi miti igamije inzira imwe na palonosetron ariko ishobora kugira igihe gito cyo gukora cyangwa ingaruka zinyuranye.
Itsinda ry'ubuvuzi rishobora kandi gutekereza ku zindi shuri ry'imiti igabanya isesemi, nk'ibinyabutabazi nka dexamethasone, dopamine antagonists nka metoclopramide, cyangwa ibishya nka olanzapine kugira ngo bagabanye isesemi ikomeye.
Uburyo bwiza bushingiye ku buryo bwawe bwihariye bwo kuvura kanseri, amateka yawe y'ubuvuzi, n'uburyo wabyitwayemo ku miti yabanje yo kugabanya isesemi. Umuganga wawe w'inzobere mu kuvura kanseri azakorana nawe kugira ngo abone uruvange rukora neza ku miterere yawe.
Netupitant na palonosetron muri rusange bitanga uburinzi buruta ubwundi ku kuruka no kuribwa mu nda biterwa na chimiothérapie ugereranije na ondansetron yonyine. Ubu buryo bwo guhuza imiti bugamije inzira ebyiri zitandukanye, butanga uburinzi bwuzuye kurusha imiti imwe gusa.
Ondansetron (Zofran) ni umuti mwiza wafashije abantu batabarika, ariko ubuza gusa imikorere ya reseptori za 5-HT3. Ku miti ya chimiothérapie ikomeye itera kuruka, kubuza inzira imwe gusa ntishobora gutanga uburinzi bwuzuye, cyane cyane mu gihe cyo gutinda kibaho nyuma yiminsi yo kuvurwa.
Inyigo za muganga zagaragaje ko umuti uhuza netupitant na palonosetron ufite akamaro kanini mu gukumira kuribwa mu nda vuba (bibaho mu masaha 24) no kuribwa mu nda bitinda (bibaho mu masaha 24-120 nyuma ya chimiothérapie) ugereranije na ondansetron yonyine.
Ariko, "kuruta" biterwa n'uko ubuzima bwawe bwifashe. Ondansetron ishobora kuba ikwiriye neza ku miti ya chimiothérapie idakomeye itera kuruka, kandi akenshi ihendutse kandi iboneka hose. Umuganga wawe azatekereza ku mbaraga za chimiothérapie yawe, ibintu bigushyira mu kaga ko kuribwa mu nda, n'ubwishingizi bwawe mugihe atanga inama.
Intego ni ukubona uburyo bukwiye bwo gukora neza, kwihanganira, no gukora neza gahunda yawe yihariye yo kuvurwa. Ikintu cyingenzi ni ugukumira kuribwa mu nda no kuruka kugirango ushobore kurangiza neza ubuvuzi bwawe bwa kanseri.
Yego, netupitant na palonosetron muri rusange birinzwe ku bantu barwaye diyabete. Uyu muti ntugira ingaruka zigorora ku rugero rw'isukari mu maraso, bityo ntuzabangamira imicungire ya diyabete yawe.
Ariko, niba umuti utera kugabanya ubushake bwo kurya cyangwa impinduka mu buryo bwo kurya, ibi bishobora kugira ingaruka ku mikorere y'isukari mu maraso yawe. Ni ngombwa gukurikirana urugero rw'isukari mu maraso yawe nk'ibisanzwe kandi ukorane n'ikipe yawe y'ubuzima kugira ngo uhindure imiti ya diyabete niba bikenewe mugihe cya chimiothérapie.
Niba uruka nubwo wafashe umuti, ibi nabyo bishobora kugira ingaruka ku isukari yo mu maraso yawe no ku kigereranyo cy'amazi mu mubiri wawe. Menyesha ikipe yawe ya oncologie ibyerekeye diyabete yawe kugira ngo bashobore guhuza ubuvuzi na endocrinologue yawe cyangwa umuganga w'ibanze.
Niba ufata umuti mwinshi mu buryo butunganye kuruta urugero rwanditswe, vugana n'umuganga wawe cyangwa ikigo gishinzwe kurwanya uburozi ako kanya. Ntukegere ngo urebe niba ibimenyetso bigaragara, kuko gusuzuma vuba ni ngombwa ku mutekano wawe.
Gufata umuti mwinshi bishobora gutera ingaruka zikomeye, harimo impinduka mu mutima, isereri rikomeye, cyangwa izindi ngorane. Ingaruka zizewe ziterwa n'umuti mwinshi wafashwe n'ibintu by'ubuzima bwawe bwite.
Igihe uhamagaye kugira ngo ufashwe, ujyane icupa ry'umuti kugira ngo utange amakuru yihariye kubyo wafashe n'igihe. Niba bishoboka, ujyane n'umuntu ushobora kugufasha kuvugana n'abaganga niba wumva utameze neza.
Kugira ngo wirinde gufata imiti myinshi mu buryo butunganye, bika umuti wawe mu icupa ry'umwimerere rifite ibirango bisobanutse, kandi ushobora gukoresha umuteguro w'ibinini niba ufata imiti myinshi. Ntukigere ufata urugero rw'inyongera niba utazi neza niba umaze gufata urugero rwawe rwatanzwe.
Niba utasohoje urugero rwawe rwatanzwe mbere ya chimiothérapie, vugana n'umuganga wawe ako kanya kugira ngo akuyobore. Igihe cy'uyu muti ni ingenzi mu kurwanya isesemi no kuruka neza.
Ntugafate doze ebyiri kugira ngo usimbure doze wasibye, kuko ibyo bishobora kongera ibyago byo kugira ingaruka zidakurikira. Itsinda ryawe ryita ku buzima rishobora guhindura gahunda yawe ya chimiothérapie cyangwa rigatanga imiti ivura isesemi kugira ngo wemeze ko urinzwe.
Niba ubonye ko wasibye doze nyuma yuko chimiothérapie yawe yatangiye, umuganga wawe ashobora kukwandikira imiti yo kugufasha gucunga isesemi cyangwa kuruka bibaye. Bazanaganira kandi ku buryo bwo kubuza ibi bitazongera kubaho mu kuvurwa kw'ejo hazaza.
Tekereza gushyiraho ibyibutsa kuri telefone yawe cyangwa gusaba umuntu wo mu muryango wawe kugufasha kwibuka igihe cy'imiti y'ingenzi. Abantu benshi babona ko bifasha gufata umuti icyarimwe n'ibindi bikorwa bisanzwe, nk'ifunguro rya mu gitondo ku munsi wo kuvurwa.
Ubusanzwe ushobora kureka gufata uyu muti urangije kuvurwa na chimiothérapie, ariko igihe nyacyo kigomba gushyirwaho n'umuganga wawe. Abantu bamwe bashobora gukenera ubufasha bukomeje bwo kurwanya isesemi mu byiciro bike nyuma ya doze ya nyuma ya chimiothérapie.
Ntukareke gufata umuti wenyine, kabone niyo wumva umeze neza cyangwa utarigeze ugira isesemi mu kuvurwa kwabanje. Intego ni ukurinda, kandi kureka kare bishobora kukuvana mu bihe bikomeye bishobora kubangamira kuvurwa kwawe kanseri.
Umuvuzi wawe w'indwara z'umubiri azatekereza ibintu nk'uburyo wabyakiriye muri rusange, ubuvuzi ubwo aribwo bwose burimo gukorwa, n'ibyago byawe byo kugira isesemi itinda iyo afata icyemezo cyo kureka umuti. Bashobora kugabanya buhoro buhoro imiti irwanya isesemi aho kureka byose icyarimwe.
Niba ufite impungenge zerekeye ingaruka zidakurikira cyangwa amafaranga, ganira kuri ibi bibazo n'itsinda ryawe ryita ku buzima aho kureka umuti wenyine. Bashobora guhindura gahunda yawe cyangwa bagatanga izindi nzira zikwiriye neza ibyo ukeneye.
Muri rusange, ni byiza kwirinda inzoga mugihe ukoresha uyu muti no mugihe uvurwa na chimiothérapie. Inzoga irashobora kongera ibyago byo kugira ingaruka zimwe na zimwe nk'izindi, no gukererwa, kandi irashobora no kubangamira umubiri wawe mu gukira chimiothérapie.
Inzoga irashobora kandi kurakaza igifu cyawe kandi igashobora gutera isesemi, ibyo bikaba bituma utagera ku ntego yo gufata imiti irwanya isesemi. Byongeye kandi, inzoga irashobora guhura n'indi miti ushobora gufata nk'igice cyo kuvurwa kanseri yawe.
Niba uhisemo kunywa inzoga rimwe na rimwe, banza ubiganireho n'umuganga wawe. Bazatanga ubuyobozi bwihariye bushingiye ku buzima bwawe muri rusange, indi miti, na gahunda yo kuvura. Ibice bito birashobora kwemerwa mubibazo bimwe na bimwe, ariko iki cyemezo kigomba gufatwa hamwe n'ubuyobozi bw'abaganga.
Shyira imbaraga mu kuguma ufite amazi menshi n'ibindi byunywa bifitiye ubuzima bwiza mugihe uvurwa. Umubiri wawe ukeneye imirire myiza n'amazi menshi kugirango ukore neza chimiothérapie kandi ukire hagati y'imiti.
Get clear medical guidance
on symptoms, medications, and lab reports.